Palo Alto, CA, United States of America

Emmanuel J M Mignot


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emmanuel J M Mignot: Innovator in CNS Disorders Treatment

Introduction

Emmanuel J M Mignot is a prominent inventor based in Palo Alto, CA, known for his significant contributions to the field of Central Nervous System (CNS) disorders. With a total of three patents to his name, Mignot has focused on developing innovative treatments that address critical health issues related to sleep and CNS disorders.

Latest Patents

Mignot's latest patents include groundbreaking inventions aimed at treating CNS disorders using CNS target modulators. One notable invention is directed to compositions and methods useful for treating CNS disorders, specifically focusing on the use of derivatized histamine antagonists for the treatment of sleep disorders. Another patent emphasizes the use of derivatized doxepins and their analogs, which are beneficial for addressing sleep disorders.

Career Highlights

Mignot has made a significant impact in the medical field through his work at Hypnion, Inc. His research and inventions have paved the way for new therapeutic approaches to managing CNS disorders, showcasing his dedication to improving patient outcomes.

Collaborations

Mignot has collaborated with notable colleagues, including Dale M Edgar and David G Hangauer, to further advance research in the treatment of CNS disorders. Their combined expertise has contributed to the development of innovative solutions in this critical area of healthcare.

Conclusion

Emmanuel J M Mignot's work exemplifies the spirit of innovation in the treatment of CNS disorders. His patents and collaborations reflect a commitment to enhancing the understanding and management of sleep and CNS-related health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…